Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization (Q57987901)

From Wikidata

Jump to navigation Jump to search

article by Jin-Kyu Kang et al published 8 May 2012 in Cancer

Language	Label	Description	Also known as
English	Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization	article by Jin-Kyu Kang et al published 8 May 2012 in Cancer

Statements

scholarly article

0 references

Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization (English)

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Jin-Kyu Kang

1

0 references

Mi-Sook Kim

2

0 references

Chul Koo Cho

3

0 references

Kwang Mo Yang

4

0 references

Hyung Jun Yoo

5

0 references

Jin Ho Kim

6

0 references

Sun Hyun Bae

7

0 references

Da Hoon Jung

8

0 references

Kum Bae Kim

9

0 references

Dong Han Lee

10

0 references

Chul Ju Han

11

0 references

Jin Kim

12

0 references

Su Cheol Park

13

0 references

Young Han Kim

14

0 references

language of work or name

0 references

publication date

8 May 2012

0 references

number of pages

8

1 reference

based on heuristic

inferred from page(s)

0 references

118

0 references

21

0 references

5424-5431

0 references

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Stereotactic body radiotherapy for primary hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Stereotactic body radiation therapy for inoperable early stage lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

21 January 2018

Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

7 January 2021

based on heuristic

inferred from DOI database lookup

Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27533

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.27533

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57987901&oldid=1977757824"